Innovative IVF enhancements & prenatal screening
To help increase your chances of conceiving successfully, we offer innovative fertility enhancements and prenatal testing. Throughout your fertility journey, we’ll determine if these reproductive technologies could be beneficial to your specific situation and needs.
Preimplantation Genetic Testing (PGT-A)
(formerly known as PGS, Preimplantation Genetic Screening) is used to identify embryos that may be affected by chromosomal abnormalities. PGT-A increases your chances of pregnancy and delivering a healthy baby while it decreases your likelihood to miscarry. PGT-A also enables confident single embryo transfer, avoiding health complications associated with twin or triplet pregnancies. An additional benefit of PGT-A is that it can reduce the number of IVF cycles you require to achieve pregnancy, potentially reducing the time and costs of extra cycles.
Preimplantation Genetic Testing (PGT-M)
This screening identifies specific genetic conditions in embryos and is accurate at least 90% of the time. PGT-M helps us select the healthiest embryo before they are transferred to the uterus. You may consider this genetic testing if you or your partner have a family history of genetic diseases such as cystic fibrosis, fragile X syndrome, muscular dystrophy, Huntington’s disease, and others.
EMBRACE (Embryo Analysis of Culture Environment)
This preimplantation genetic screening method is a non-invasive test that collects DNA from the culture medium (a drop of liquid where the embryos develop) without disturbing the embryo itself, and send it for testing. The result from the DNA testing indicates which embryos are more likely to be chromosomally normal, and therefore optimal for transfer, maximizing your chances of a healthy pregnancy.
Endometrial Receptivity Analysis (ERA)
ERA is helpful for patients who have experienced multiple embryo failures. It can help identify the ideal timeframe for embryo implantation to occur, i.e. when endometrial cells are most receptive providing the embryo with better chances to attach. Your physician may recommend this procedure to ensure you are at the maximal endometrial receptivity to increase your chances of conception.
Non-invasive Prenatal Testing (NIPT Harmony)
NIPT is a screening test performed on a blood draw taken after 10 weeks into the pregnancy. It screens for the most common chromosomal conditions (trisomies 21, 18, and 13).
Why get NIPT?
Humans have 23 pairs of chromosomes which are DNA strands carrying genes. A trisomy occurs when there’s an extra chromosome. These commonly occur at position 21 (Down syndrome), position 18 (Edwards syndrome), and position 13 (Patau syndrome).
Harmony non-invasive prenatal testing has a detection rate of over 99%, and a false positive rate of less than 0.1% for trisomy 21 and less than 0.15% for all trisomies combined.